ENFOQIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Aug 2025)
What this means for you
This application is over — abandoned 18 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98416392
- Mark type
- Stylized text
- Filed
- 22 Feb 2024
- Published for opposition
- 21 May 2024
- Abandoned
- 18 Aug 2025
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owner
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
Prosecution history
- 18 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2024 — SOU EXTENSION 1 GRANTED
- 26 Nov 2024 — SOU EXTENSION 1 FILED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION
- 01 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED